| 481 |
Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 482 |
Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 483 |
Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 484 |
Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4- (methylsulfonyl) phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors |
|
2021 |
| 485 |
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 486 |
Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles |
Department of Pharmaceutics |
2021 |
| 487 |
Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles |
Department of Pharmaceutics |
2021 |
| 488 |
Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles |
Department of Pharmaceutics |
2021 |
| 489 |
Development of new hetero‑steroid hybrids with antiproliferative activity against MCF‑7 breast cancer cells |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 490 |
Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities |
Department of Industrial Pharmacy |
2021 |